The coagulation factor Xa is a new target in anti-glioblastoma therapy

S. Kuhn, L. Handel, L. Liebmann, S. Frank & R. Kalff
Objective: Patients with glioblastomas often suffer from thrombembolic complications that complicate the course of disease and reduce the patient’s quality of life or shorten the survival time in severe cases. Methods: Patients with glioblastomas (n=35) were included into a prospective[for full text, please go to the a.m. URL]